Drugs / Respatio
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT03755037 Comparator | Jan 2017 → Apr 2018 | female infertility | Nesreen Abdel Fattah Abdullah Shehata | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Respatio | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03755037 ↗ |
| Known as | sildenafil citrate | “sildenafil citrate (Respatio) 20 mg tab orally 3 times daily from8th day of same cycle till 11th day” NCT03755037 ↗ |
| Route | Oral | “sildenafil citrate (Respatio) 20 mg tab orally 3 times daily from8th day of same cycle till 11th day” NCT03755037 ↗ |